We left the briefing feeling positive on its business outlook as well as expansionary business plans to outshine the growing semiconductor industry.
After aiding the group to achieve historical high in terms of revenue and profit year after year, RF remains the chief growth driver with target of 30% yoy expansion in FY16.
Management remains bullish on RF’s demand and sees great potential to capitalize on the LTE deployments in China, India, Middle East, Africa and Turkey.
While RF’s output volume will not surge significantly, module complexity thanks to miniaturization has led to higher chip density/content which bode well for Inari.
FY16 CAPEX is expected to reach RM110m which can be broken down into RM45m for machinery capacity expansion, RM20m for automation/improvement, RM10m for probers for wafer testing and RM35m for factory floor space expansion (P13 extension/lease/acquire).
Shared that several sections in P13 are on track for transfer and qualification with expectations to start contribution to the group, including SMT and level 2 Room 1 Test in Jul 2015 as well as chip fab in Jan 2016.
After ploughing much into fibre optic R&D, Inari believes that it is ripe for monetization. ISK has the competencies in product development, validation, manufacturing and testing. After inking a licensing agreement with Avago, it will extend its capability into sales and marketing for its products.
Forecasts
Updated model based on latest guidance mainly on capacity, CAPEX and new FOREX assumption of RM3.80/USD. In turn, this has led to upward adjustments in FY16-17 FD EPS by 0.9% and 5.4%, respectively.
Business diversifications into optoelectronics and T&M.
Favorable FOREX.
Continuous effective operational strategy.
Risks
Major client risk (Avago) / high dependency.
FOREX risks.
Patent disputes.
Resources / labour shortage.
Rating
BUY , TP: RM3.79
Positives
Appreciation of greenback, 40% dividend payout providing reasonable yield and strong earnings growth.
Negatives
Innovation stalemate in telecommunication.
Valuation
Reiterate BUY after raising TP by 3.3% from RM3.67 to RM3.79 reflecting the upward earnings revisions.
Our fair value is pegged to unchanged P/E multiple of 15x CY16 FD EPS, 10% premium to global peers’ average P/E which is justifiable given the stronger greenback and high growth ahead (see Figure #2).
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....